Cryoport, Inc. — Director's Dealing 2021

Sep 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2021-09-13

Reporting Person: BERMAN RICHARD J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-13	Common Stock	M	14134	$14.35	Acquired	114134	Direct
2021-09-13	Common Stock	M	10866	$18.02	Acquired	125000	Direct
2021-09-15	Common Stock	S	3703	$62.7236	Disposed	121297	Direct
2021-09-15	Common Stock	S	15073	$64.0764	Disposed	106224	Direct
2021-09-15	Common Stock	S	6224	$64.5543	Disposed	100000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-13	Options to purchase common stock	$14.35	M	14134	Disposed	2029-05-02	Common Stock (14134)	Direct
2021-09-13	Options to purchase common stock	$18.02	M	10866	Disposed	2030-05-01	Common Stock (10866)	Direct

Footnotes

F1: 1/12 of these options vested and became exercisable on the 1st of each month for twelve (12) months beginning on 05/02/2019.

F2: 1/12 of these options vested and became exercisable on the 1st of each month for twelve (12) months beginning on 06/01/2020.

F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.38 to $63.32, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.40 to $64.39, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.40 to $64.923, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.